spacer

Welcome to Intelesens

Advances in medical technology, including wireless connectivity and wearable mobile devices are providing practitioners, medical centres and hospitals with important clinical tools to reach and care for patients in new and innovative ways. Intelesens is at the forefront of this technology.

Our range of CE approved and FDA cleared products, when combined with our Canberra database, provide monitoring solutions that offer improved quality of care to patients and cost savings to healthcare providers. Our products can:

Our portfolio of products, which have undergone a range of clinical trials to prove they satisfy the current demand in innovative wireless technology, include: the V-Patch - a wireless GPRS Cardiac Arrhythmia Detection Device; Vitalsens VS 100 - utilising Bluetooth technology; and Aingeal VS 200 - our in-hospital wi-fi device which monitors respiration in addition to ECG, heart rate, skin temperature and motion.

The Intelesens mission is to continue to provide innovative technologies and products which will improve the quality of care for ageing and ill populations, and in response to the broader needs of the monitoring market we shall soon be including 24-hour ECG full disclosure and pulse oximetry to our existing vital signs parameters.

A university spin-out company, Intelesens maintains a dynamic collaborative relationship with world-class research teams in the Nanotechnology and Integrated BioEngineering Centre (NIBEC) based at the University of Ulster in Northern Ireland. Our products deliver real benefits for all key players in the value chain, in a marketplace with a rapidly growing demand and where wireless sensors and networks are estimated to reduce annual health care costs in the US by $25 billion by 2012.

Click here to download our latest brochure.


gipoco.com is neither affiliated with the authors of this page nor responsible for its contents. This is a safe-cache copy of the original web site.